Unfavourable outcomes were first reported in relation to inappropriate tumour BCL2 protein expression in follicular lymphoma as a result of a chromosomal translocation t (14,18) (Tsujimoto et al. 1984). This evidence concerns the gene BCL2 and neoplasm.